Literature DB >> 1381250

Medical treatment for benign prostatic hyperplasia.

C Chapple.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1381250      PMCID： PMC1881763          DOI： 10.1136/bmj.304.6836.1198

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  13 in total

1.  Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck.

Authors:  M Caine; S Raz; M Zeigler
Journal:  Br J Urol       Date:  1975-04

2.  Use of an alpha 1-blocker, YM617, in the treatment of benign prostatic hypertrophy. YM617 Clinical Study Group.

Authors:  K Kawabe; A Ueno; Y Takimoto; Y Aso; H Kato
Journal:  J Urol       Date:  1990-10       Impact factor: 7.450

3.  A double-blind controlled trial of a new alpha-1 blocking drug in the treatment of bladder outflow obstruction.

Authors:  J W Ramsay; G I Scott; H N Whitfield
Journal:  Br J Urol       Date:  1985-12

4.  Urinary incontinence caused by prazosin.

Authors:  T Thien; K P Delaere; F M Debruyne; R A Koene
Journal:  Br Med J       Date:  1978-03-11

5.  A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction.

Authors:  M Caine; S Perlberg; S Meretyk
Journal:  Br J Urol       Date:  1978-12

6.  Characterisation of human prostatic adrenoceptors using pharmacology receptor binding and localisation.

Authors:  C R Chapple; M L Aubry; S James; P M Greengrass; G Burnstock; R T Turner-Warwick; E J Milroy; M J Davey
Journal:  Br J Urol       Date:  1989-05

7.  A twelve-week placebo-controlled study of prazosin in the treatment of prostatic obstruction.

Authors:  C R Chapple; T J Christmas; E J Milroy
Journal:  Urol Int       Date:  1990       Impact factor: 2.089

8.  Indoramin in the treatment of prostatic bladder outflow obstruction.

Authors:  M A Stott; P Abrams
Journal:  Br J Urol       Date:  1991-05

9.  Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.

Authors:  W J Catalona; D S Smith; T L Ratliff; K M Dodds; D E Coplen; J J Yuan; J A Petros; G L Andriole
Journal:  N Engl J Med       Date:  1991-04-25       Impact factor: 91.245

10.  Effects of prazosin in patients with benign prostatic obstruction.

Authors:  H Hedlund; K E Andersson; A Ek
Journal:  J Urol       Date:  1983-08       Impact factor: 7.450
View more
  7 in total

1.  How should new treatments for benign prostatic hyperplasia be assessed?

Authors:  D Kirk
Journal:  BMJ       Date:  1993-05-15

2.  Proteolyzed Variant of IgG with Free C-Terminal Lysine as a Biomarker of Prostate Cancer.

Authors:  Anna Lokshin; Lyudmila M Mikhaleva; Eugene I Goufman; Marina N Boltovskaya; Natalia B Tikhonova; Irina I Stepanova; Alexandr A Stepanov; Natalia V Potoldykova; Andrey Z Vinarov; Paul Stemmer; Vasily Iakovlev
Journal:  Biology (Basel)       Date:  2021-08-23

Review 3.  Silodosin is effective for treatment of LUTS in men with BPH: a systematic review.

Authors:  Hui Ding; Wan Du; Zi-Zhen Hou; Han-Zhang Wang; Zhi-Ping Wang
Journal:  Asian J Androl       Date:  2012-12-10       Impact factor: 3.285

4.  Non-Hormonal treatment of BPH/BOO.

Authors:  Nadir I Osman; Altaf Mangera; Christopher R Chapple
Journal:  Indian J Urol       Date:  2014-04

5.  Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies.

Authors:  Xiaoyu Dai; Xiangming Fang; Ying Ma; Jianbo Xianyu
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

6.  Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients.

Authors:  Sung Han Kim; Whi An Kwon; Jae Young Joung
Journal:  World J Mens Health       Date:  2020-02-05       Impact factor: 5.400

7.  Detection and Investigation of Extracellular Vesicles in Serum and Urine Supernatant of Prostate Cancer Patients.

Authors:  Samanta Salvi; Erika Bandini; Silvia Carloni; Valentina Casadio; Michela Battistelli; Sara Salucci; Ilaria Erani; Emanuela Scarpi; Roberta Gunelli; Giacomo Cicchetti; Michele Guescini; Massimiliano Bonafè; Francesco Fabbri
Journal:  Diagnostics (Basel)       Date:  2021-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.